The Safety and Hemodynamic Effects of Pneumatic Sleeves in Patients with Severe Left Ventricular Dysfunction. 2019

Gassan Moady, and Amitai Bickel, and Alexander Shturman, and Muhammad Khader, and Shaul Atar
Department of Cardiology, Galilee Medical Center, Nahariya, Israel.

BACKGROUND Pneumatic sleeves (PS) are often used during laparoscopic surgery and for prevention of deep vein thrombosis in patients who cannot receive anticoagulation treatment. There is very little information on the hemodynamic changes induced by PS and their effect on brain natriuretic peptide (BNP) in patients with severely reduced left ventricular ejection function (LVEF). OBJECTIVE To determine the safety and hemodynamic changes induced by PS and their effects on brain natriuretic peptide (BNP). METHODS This study comprised 14 patients classified as New York Heart Association (NYHA) II-III with severely reduced LVEF (< 40%). We activated the PS using two inflation pressures (50 or 80 mmHg, 7 patients in each group) at two cycles per minute for one hour. We measured echocardiography, hemodynamic parameters, and BNP levels in each patient prior to, during, and after the PS operation. RESULTS The baseline LVEF did not change throughout the activation of PS (31 ± 10% vs. 33 ± 9%, P = 0.673). Following PS activation there was no significant difference in systolic or diastolic blood pressure, the pulse measurements, or central venous pressure. BNP levels did not change after PS activation (P = 0.074). CONCLUSIONS The use of PS, with either low or high inflation pressures, is safe and has no detrimental effects on hemodynamic parameters or BNP levels in patients with severely reduced LVEF following clinical stabilization and optimal medical therapy.

UI MeSH Term Description Entries
D008297 Male Males
D004452 Echocardiography Ultrasonic recording of the size, motion, and composition of the heart and surrounding tissues. The standard approach is transthoracic. Echocardiography, Contrast,Echocardiography, Cross-Sectional,Echocardiography, M-Mode,Echocardiography, Transthoracic,Echocardiography, Two-Dimensional,Transthoracic Echocardiography,2-D Echocardiography,2D Echocardiography,Contrast Echocardiography,Cross-Sectional Echocardiography,Echocardiography, 2-D,Echocardiography, 2D,M-Mode Echocardiography,Two-Dimensional Echocardiography,2 D Echocardiography,Cross Sectional Echocardiography,Echocardiography, 2 D,Echocardiography, Cross Sectional,Echocardiography, M Mode,Echocardiography, Two Dimensional,M Mode Echocardiography,Two Dimensional Echocardiography
D005260 Female Females
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D048228 Intermittent Pneumatic Compression Devices Instruments that generate intermittent forces, uniformed or graduated, to facilitate the emptying of VEINS. These devices are used to reduce limb EDEMA and prevent venous THROMBOEMBOLISM, such as deep vein thrombosis in the legs. Compression Devices, Intermittent Pneumatic,Intermittent Pneumatic Compression Device,Pneumatic Compression Stocking,Pneumatic Compression Stockings,Pneumatic Compression Hose,Pneumatic Hose,Pneumatic Intermittent Impulse Device,Compression Hose, Pneumatic,Compression Stocking, Pneumatic,Compression Stockings, Pneumatic,Hose, Pneumatic,Hose, Pneumatic Compression,Stocking, Pneumatic Compression,Stockings, Pneumatic Compression
D018487 Ventricular Dysfunction, Left A condition in which the LEFT VENTRICLE of the heart was functionally impaired. This condition usually leads to HEART FAILURE; MYOCARDIAL INFARCTION; and other cardiovascular complications. Diagnosis is made by measuring the diminished ejection fraction and a depressed level of motility of the left ventricular wall. LV Diastolic Dysfunction,LV Dysfunction,LV Systolic Dysfunction,Left Ventricular Diastolic Dysfunction,Left Ventricular Dysfunction,Left Ventricular Systolic Dysfunction,Diastolic Dysfunction, LV,Dysfunction, LV,Dysfunction, LV Diastolic,Dysfunction, LV Systolic,Dysfunction, Left Ventricular,LV Diastolic Dysfunctions,LV Dysfunctions,LV Systolic Dysfunctions,Left Ventricular Dysfunctions,Systolic Dysfunction, LV
D020097 Natriuretic Peptide, Brain A PEPTIDE that is secreted by the BRAIN and the HEART ATRIA, stored mainly in cardiac ventricular MYOCARDIUM. It can cause NATRIURESIS; DIURESIS; VASODILATION; and inhibits secretion of RENIN and ALDOSTERONE. It improves heart function. It contains 32 AMINO ACIDS. Brain Natriuretic Peptide,Nesiritide,B-Type Natriuretic Peptide,BNP Gene Product,BNP-32,Brain Natriuretic Peptide-32,Natrecor,Natriuretic Factor-32,Natriuretic Peptide Type-B,Type-B Natriuretic Peptide,Ventricular Natriuretic Peptide, B-type,BNP 32,Brain Natriuretic Peptide 32,Natriuretic Factor 32,Natriuretic Peptide Type B,Natriuretic Peptide, B-Type,Natriuretic Peptide, Type-B,Natriuretic Peptide-32, Brain,Peptide, Brain Natriuretic,Peptide-32, Brain Natriuretic,Type B Natriuretic Peptide,Ventricular Natriuretic Peptide, B type

Related Publications

Gassan Moady, and Amitai Bickel, and Alexander Shturman, and Muhammad Khader, and Shaul Atar
September 1988, Circulation,
Gassan Moady, and Amitai Bickel, and Alexander Shturman, and Muhammad Khader, and Shaul Atar
November 1991, American heart journal,
Gassan Moady, and Amitai Bickel, and Alexander Shturman, and Muhammad Khader, and Shaul Atar
January 1989, Journal of cardiovascular pharmacology,
Gassan Moady, and Amitai Bickel, and Alexander Shturman, and Muhammad Khader, and Shaul Atar
October 2014, Journal of cardiac failure,
Gassan Moady, and Amitai Bickel, and Alexander Shturman, and Muhammad Khader, and Shaul Atar
June 1989, The American journal of cardiology,
Gassan Moady, and Amitai Bickel, and Alexander Shturman, and Muhammad Khader, and Shaul Atar
September 2018, Cardiovascular revascularization medicine : including molecular interventions,
Gassan Moady, and Amitai Bickel, and Alexander Shturman, and Muhammad Khader, and Shaul Atar
April 1990, Journal of the American College of Cardiology,
Gassan Moady, and Amitai Bickel, and Alexander Shturman, and Muhammad Khader, and Shaul Atar
January 1992, European heart journal,
Gassan Moady, and Amitai Bickel, and Alexander Shturman, and Muhammad Khader, and Shaul Atar
July 1991, [Zasshi] [Journal]. Nihon Kyobu Geka Gakkai,
Gassan Moady, and Amitai Bickel, and Alexander Shturman, and Muhammad Khader, and Shaul Atar
October 1999, The American journal of cardiology,
Copied contents to your clipboard!